EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 5 (Mai 2007) Med Sci (Paris), 23 5 (2007) 515-518 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 5, Mai 2007
Page(s) 515 - 518
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007235515
Published online 15 May 2007
  1. Ohta T, Elnemr A, Yamamoto M, et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3. Int J Oncol 2002; 21 : 37–42. [Google Scholar]
  2. Lampen A, Grimaldi PA, Nau H. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation. Mol Pharmacol 2005; 68 : 193–203. [Google Scholar]
  3. Collet P, Domenjoud L, Devignes MD, et al. The human semaphorin 6B is down regulated by PPARs. Genomics 2004; 83 : 1141–50. [Google Scholar]
  4. Bloch-Gallego E, Sotelo C. Chimio-attraction ou chimio-répulsion axonale : rôle des nétrines et des sémaphorines. Med Sci (Paris) 1998; 14 : 44–52. [Google Scholar]
  5. Murad H, Collet P, Huin-Schohn C, et al. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells. Int J Oncol 2006; 28 : 977–84. [Google Scholar]
  6. Wang N, Verna L, Chen NG, et al. Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 2002; 277 : 34176–81. [Google Scholar]
  7. Jackson SM, Parhami F, Xi XP, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscl Thromb Vasc 1999; 19 : 2094–104. [Google Scholar]
  8. Imamoto E, Yoshida N, Uchiyama K, et al. Inhibitory effect of pioglitazone on expression of adhesion molecules on neutrophils and endothelial cells. Biofactors 2004; 20 : 37–47. [Google Scholar]
  9. Sasaki M, Jordan P, Welbourne T, et al. Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated par TNF-α BMC Physiol 2005; 5 : 3. [Google Scholar]
  10. Kurebayashi S, Xu X, Ishii S, et al. A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells. Atherosclerosis 2005; 182 : 71–7. [Google Scholar]
  11. Lieu D, Zeng BX, Zhang SH, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 2005; 54 : 464–70. [Google Scholar]
  12. Besson VC, Chen XR, Plotkine M, et al. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett 2005; 388 : 7–12. [Google Scholar]
  13. Vlaeminck-Guillem V, Laudet V, Duterque-Coquillaud M. Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis. Med Sci (Paris) 2003; 19 : 1121–7. [Google Scholar]
  14. Hazra S, Miyahara T, Rippe RA, et al. PPAR gamma and hepatic stellate cells. Comp Hepatol 2004; 3 : 57–9. [Google Scholar]
  15. Yavrom S, Chen L, Xiong S, et al. Peroxisome proliferator-activated receptor γ suppresses proximal α1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem 2005; 280 : 40650–9. [Google Scholar]
  16. Masamune A, Kikuta K, Satoh M, et al. Ligands of peroxisome proliferator-activated receptor γ block activation of pancreatic stellate cells. J Biol Chem 2002; 277 : 141–7. [Google Scholar]
  17. Van Westerloo DJ, Florquin S, de Boer AM, et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005; 166 : 721–8. [Google Scholar]
  18. Burgess HA, Daugherty LE, Thatcher TH, et al. PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production : implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005; 288 : L1146–53. [Google Scholar]
  19. Zafiriou S, Stanners SR, Saad S, et al. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. J Am Soc Nephrol 2005; 16 : 638–45. [Google Scholar]
  20. Chen K, Chen J, Li D, et al. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts. Modulation by PPAR-γ ligand pioglitazone. Hypertension 2004; 44 : 655–61. [Google Scholar]
  21. Guo B, Koya D, Isono M, et al. Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes 2004; 53 : 200–8. [Google Scholar]
  22. Maeda A, Horikoshi S, Godha T, et al. Pioglitazone attenuates TGF-β1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)γ. Cell Biol Int 2005; 29 : 422–8. [Google Scholar]
  23. Panchapakesan U, Sumual C, Pollock CA, et al. PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 2005; 289 : F1153–8. [Google Scholar]
  24. Han SW, Ritzenthaler JD, Rivera HN, et al. Peroxisome proliferator-activated receptor-γ ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol 2005; 289 : L419–28. [Google Scholar]
  25. Han S, Rivera HN, Roman J. Peroxisome proliferator-activated receptor-γ ligands inhibit α5 integrin gene transcription in non-small cell lung carcinoma cells. Am J Respir Cell Mol Biol 2005; 32 : 350–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.